Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Bio-Tech Development Center (BBDC) is a state-affiliated organization established in 1988 to spearhead the growth of the biotechnology and pharmaceutical industries in Beijing. Operating under the guidance of the Beijing Municipal Science & Technology Commission, it serves as a strategic coordinator, incubator, and investment vehicle for the regional life sciences ecosystem. BBDC is primarily responsible for managing the Zhongguancun Life Science Park and implementing the G20 Project, a municipal initiative designed to scale high-potential pharmaceutical and medical technology companies. The organization provides essential infrastructure, R&D funding, and international collaboration opportunities to accelerate the commercialization of innovative medical products. It acts as a bridge between government policy, academic research, and industrial application, fostering innovation in areas such as genomics, drug discovery, and high-end medical devices. While not a direct therapeutic developer, BBDC plays a pivotal role in the industrialization of biotechnology in Northern China through its extensive portfolio of supported enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Bio-Tech Development.